Idiopathic Nephrotic Syndrome Recruiting Phase 3 Trials for Prednisone (DB00635)

IndicationStatusPhase
DBCOND0033235 (Idiopathic Nephrotic Syndrome)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03298698Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic SyndromeTreatment